Table 1 Numbers of new presentations and age standardised incidence rates by sex and study year.

Study year	Patient years	Carpal tunnel syndrome		Morton's metatarsalgia		Ulnar neuropathy		Meralgia paraesthetica		Radial neuropathy
		n	ASR*	n	ASR*	n	ASR*	n	ASR*	n	ASR*
Women
1992	881501	1570	170.0	682	76.3	155	17.3	93	10.0	8	0.72
1993	893406	1954	207.5	763	82.7	161	17.3	87	8.92	13	1.25
1994	908763	1842	192.3	753	81.7	143	15.2	104	11.1	15	1.55
1995	918763	1787	183.1	773	82.1	148	15.6	128	13.5	17	1.83
1996	915999	1775	181.5	819	87.3	166	16.8	108	11.6	12	1.31
1997	918483	1741	174.6	772	79.2	170	16.7	122	12.7	16	1.53
1998	922287	1835	183.1	806	82.2	162	16.5	127	13.6	14	1.37
1999	927781	1888	188.2	835	86.2	196	20.3	112	11.1	19	1.82
2000	928747	1952	192.8	866	87.5	187	18.9	130	13.2	14	1.42
p value (trend by year)			0.945		0.055		0.125		0.057		0.147
Period prevalence up to 2000†		20895	2016	8496	821.9	1735	170.4	1111	108.2	150	15.0
Men
1992	847536	572	64.8	360	41.3	169	19.1	92	10.5	19	2.06
1993	860398	682	75.4	343	38.4	196	21.9	105	12.0	27	3.01
1994	875779	737	80.1	425	46.6	211	23.2	102	11.2	23	2.58
1995	886346	675	72.5	431	46.8	201	22.0	98	10.7	26	2.77
1996	885012	713	75.6	432	46.1	208	22.5	98	10.4	28	3.01
1997	889319	682	71.5	465	49.2	216	22.7	115	12.3	25	2.51
1998	894318	775	79.1	448	46.7	221	23.3	113	11.8	22	2.31
1999	900193	801	83.1	421	43.9	272	28.6	116	12.3	26	2.76
2000	902973	877	87.8	488	50.2	240	25.2	104	10.7	29	2.97
p value (trend by year)			0.019		0.048		0.011		0.493		0.456
Period prevalence up to 2000†		7811	784	4419	446.2	2291	235.0	1066	108.3	288	29.4

*ASR, age standardised incidence rate per 100 000 European standard population.

†Includes diagnoses before 1992.